AXSM: Pangali rega marang bathi Axsome Therapeutics Inc
Axsome Therapeutics (AXSM) leverages the high demand for unique CNS therapy combinations while adhering to strict environmental waste disposal regulations. The P/E ratio dynamics help assess the asset's margin of safety, where -44.70 indicates the value of this parameter. The company's active R&D pipeline is accelerating the commercialization of new treatments for migraine, depression, and narcolepsy.
Rincian metrik komprehensif lan analitis Axsome Therapeutics Inc (AXSM)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Axsome Therapeutics|AXSM - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Axsome Corp|AXSM - Gunggung utang perusahaan|Rasio utang marang aset resik Axsome Therapeutics, Inc.|AXSM - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Axsome Therapeutics|Rasio jangkoan perantara axsome.com
- rincian bathi lan kelipatan pasar:
AXSM - Bathi resik|Bathi resik sing dikarepake Axsome Therapeutics|AXSM - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Axsome|AXSM - Pangali PEG|Pangali EV/EBITDA Axsome Therapeutics, Inc.|AXSM - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Axsome Therapeutics|AXSM - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan axsome.com|AXSM - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Axsome Therapeutics
Analisis umum perusahaan:axsome.com - AXSM
The P/E ratio reflects the market value of each unit of net income, allowing for an assessment of the premium paid for future business growth. By analyzing the forward P/E of Axsome Therapeutics (AXSM), an investor separates fundamental value from volatility, which is critical for Axsome Therapeutics (AXSM), as its production outsourcing model minimizes capital expenditures and environmental risks, focusing the valuation exclusively on the efficiency of neuro-drug development.
Perusahaan pesaing
Pangali P/E biogen.com|Koefisien rega marang bathi NBIX (Neurocrine Biosciences, Inc.)|Regencell Bioscience Ltd - Pangali rega marang bathi|Rasio rega marang bathi ACADIA Pharmaceuticals Inc ACAD|Periode bali modal bisnis Xenon Corp (XENE)|VKTX - Rasio rega marang bathi|Kapitalisasi marang bathi supernus.com|Catalyst Pharmaceuticals, Inc. (CPRX) - Rasio rega marang bathi|Koefisien rega marang bathi Denali|HRMY (Harmony Pharma) - Pangali P/E|Kapitalisasi marang bathi Biohaven Corp BHVN|Koefisien rega marang bathi AMLX (Amylyx Pharmaceuticals)|TRVI (trevitherapeutics.com) - Nilai perusahaan marang bathi resik|Praxis Precision Medicines, Inc. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik AVXL (Anavex)|CeriBell Corp - Pangali P/E|Nilai perusahaan marang bathi resik PRTA (Prothena Corporation)|ALEC: Pangali P/E|Kapitalisasi marang bathi annexonbio.com (ANNX)|Rasio rega marang bathi Omeros Corp|NGNE: Nilai perusahaan marang bathi resik|Pangali P/E ACIU|Pangali P/E Voyager Corp (VYGR)|Rasio rega marang bathi Neumora Therapeutics NMRA|SCLX (scilexholding.com) - Kapitalisasi marang bathi resik|Tevogen Bio - Pangali P/E|Kapitalisasi marang bathi Alpha Cognition|CGTX (Cognition Therapeutics, Inc.) - Koefisien rega marang bathi|Inhibikase Pharma (IKT) - Pangali P/E|Koefisien rega marang bathi SAVA|ASRT (Assertio Therapeutics) - Rasio rega pasar marang bathi resik|Pangali P/E COYA|Periode bali modal bisnis vistagen.com|Pangali P/E OVID (Ovid Therapeutics)|ABOS - Koefisien rega marang bathi|CRVO - Rasio rega marang bathi|Periode bali modal bisnis Alterity Therapeutics ATHE|CLNN: Pangali P/E|PepGen (PEPG) - Pangali P/E|Koefisien rega marang bathi JUNS|Pangali rega marang bathi RLMD (Relmada Corp)|Rasio rega marang bathi Annovis Bio, Inc. (ANVS)|Periode bali modal bisnis gracetx.com|Rasio rega marang bathi Firefly Neuroscience AIFF|KLTO - Koefisien rega marang bathi|NRSN - Rasio rega marang bathi|RVPH (Reviva Pharmaceuticals, Inc.) - Pangali rega marang bathi|MTVA: Pangali P/E|Kapitalisasi marang bathi neuraxis.com (NRXS)|Koefisien rega marang bathi HSDT|Pangali P/E Passage Bio Corp|Rasio rega marang bathi Neuphoria Therapeutics Inc. (NEUP)|NERV (Minerva) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Athira Pharma, Inc. ATHA|addextherapeutics.com (ADXN) - Kapitalisasi marang bathi|Alzamend - Pangali P/E|CYCN - Pangali P/E|PTIX (protagenic.com) - Koefisien rega marang bathi|Pangali rega marang bathi KTTA|Rasio rega marang bathi Cortigent Inc|avenuetx.com (ATXI) - Periode bali modal bisnis|Rasio rega marang bathi BrainStorm Cell Therapeutics (BCLI)|CARA - Kapitalisasi marang bathi|Rasio rega marang bathi Chromocell Therapeutics Corporation CHRO|ELYM - Koefisien rega marang bathi|Intra-Cellular - Pangali P/E|Kapitalisasi marang bathi longboardpharma.com|MRNS (Marinus Pharmaceuticals, Inc.) - Koefisien rega marang bathi|NKGen Biotech Inc - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi NRBO|SAGE (Sage Therapeutics Inc) - Rasio rega pasar marang bathi resik|Pangali P/E SNPX|TRVN (trevena.com) - Nilai perusahaan marang bathi resik|Pangali P/E VIGL (Vigil Neuroscience, Inc.)|anewmeds.com (WENA) - Kapitalisasi marang bathi|CERE - Rasio rega marang bathi
